A new option is now approved to treat adults living with high-risk smoldering multiple myeloma (MM). 1 The FDA has greenlit ...
MedPage Today on MSN
Achieving Cure in Multiple Myeloma
Since the beginning of this century, advances in understanding the biology of multiple myeloma have transformed the disease ...
Heidelberg Pharma has reported encouraging progress in its phase 2/2a trial of HDP-101 (INN: pamlectabart tismanitin), its ...
You don’t expect to break a rib while doing light housekeeping. Similarly, you wouldn’t think your worsening back pain might be caused by a type of blood cancer. However, these are among classic ...
Caribou Biosciences Inc. (NASDAQ:CRBU) shares skyrocketed 100% on Monday after the company released promising Phase 1 ...
Progress has been made in identifying and treating the disease, but the impact of federal cuts is yet to be borne out.
Stem cell transplant options have expanded, utilizing matched siblings, unrelated donors, and umbilical cord blood, enhancing access for hematologic cancer patients. October brought developments in ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Jonathan L.
SAN DIEGO, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene therapy technologies into lifesaving cell therapies, is ...
CAR-T cell therapy is moving to earlier lines of multiple myeloma treatment. Elouise Wrisper’s cancer journey began with persistent back pain. It was 2021, and the retired teacher, who was active in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback